ATE179986T1 - Verfahren zur herstellung von 1-(2'-deoxy-2',2'- difluoro-d-ribofuranosyl)-4-amino-pyrimidin-2-o - hydrochlorid - Google Patents

Verfahren zur herstellung von 1-(2'-deoxy-2',2'- difluoro-d-ribofuranosyl)-4-amino-pyrimidin-2-o - hydrochlorid

Info

Publication number
ATE179986T1
ATE179986T1 AT95308030T AT95308030T ATE179986T1 AT E179986 T1 ATE179986 T1 AT E179986T1 AT 95308030 T AT95308030 T AT 95308030T AT 95308030 T AT95308030 T AT 95308030T AT E179986 T1 ATE179986 T1 AT E179986T1
Authority
AT
Austria
Prior art keywords
ribofuranosyl
deoxy
difluoro
pyrimidine
hydrochloride
Prior art date
Application number
AT95308030T
Other languages
English (en)
Inventor
Richard Alan Berglund
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23397211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE179986(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE179986T1 publication Critical patent/ATE179986T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95308030T 1994-12-13 1995-11-09 Verfahren zur herstellung von 1-(2'-deoxy-2',2'- difluoro-d-ribofuranosyl)-4-amino-pyrimidin-2-o - hydrochlorid ATE179986T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/355,372 US5637688A (en) 1994-12-13 1994-12-13 Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Publications (1)

Publication Number Publication Date
ATE179986T1 true ATE179986T1 (de) 1999-05-15

Family

ID=23397211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95308030T ATE179986T1 (de) 1994-12-13 1995-11-09 Verfahren zur herstellung von 1-(2'-deoxy-2',2'- difluoro-d-ribofuranosyl)-4-amino-pyrimidin-2-o - hydrochlorid

Country Status (31)

Country Link
US (2) US5637688A (de)
EP (1) EP0719788B1 (de)
JP (1) JPH10510806A (de)
KR (1) KR100424991B1 (de)
CN (1) CN1047177C (de)
AR (1) AR001041A1 (de)
AT (1) ATE179986T1 (de)
AU (1) AU689674B2 (de)
BG (1) BG62738B1 (de)
BR (1) BR9509979A (de)
CO (1) CO4520286A1 (de)
CZ (1) CZ290941B6 (de)
DE (1) DE69509624T2 (de)
DK (1) DK0719788T3 (de)
ES (1) ES2130542T3 (de)
GR (1) GR3030265T3 (de)
HU (1) HU219021B (de)
IL (1) IL115852A (de)
MY (1) MY112488A (de)
NO (1) NO306783B1 (de)
NZ (1) NZ296476A (de)
PE (1) PE49296A1 (de)
PL (1) PL181732B1 (de)
RO (1) RO117327B1 (de)
RU (1) RU2154648C2 (de)
SI (1) SI0719788T1 (de)
TW (1) TW379226B (de)
UA (1) UA48152C2 (de)
WO (1) WO1996018637A1 (de)
YU (1) YU49314B (de)
ZA (1) ZA959320B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
EP0870506A1 (de) * 1997-04-11 1998-10-14 Eli Lilly And Company Zusammentsetzungen enthaltend ein Cryptophycin Derivat in Kombination mit einem synchronisierten Wirkstoff oder Aktivierungsmittel zur Behandlung von Krebs
IL136462A0 (en) * 1997-12-22 2001-06-14 Schering Corp Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
US6376470B1 (en) 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
AU2001296558A1 (en) * 2000-10-03 2002-04-15 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
WO2005014010A1 (en) * 2003-07-24 2005-02-17 Eli Lilly And Company Pharmaceutical composition comprising gemcitabine and cyclodextrines
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
EP1812457A1 (de) * 2004-07-30 2007-08-01 Pharmaessentia Corp. Stereoselektive synthese von b-nukleosiden
WO2006070985A1 (en) * 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
UA88940C2 (ru) * 2005-03-04 2009-12-10 Дабур Фарма Лимитед Промежуточное соединение, способ его получения и стереоселективный способ гликозилирования
WO2006095359A1 (en) * 2005-03-10 2006-09-14 Sms Pharmaceuticals Limited Synthesis of 2-deoxy-2, 2-di fluoro-d-ribo furanose-3, 5 di(4-methy/4-nitro-chloro)benzoate and its conversion to gemcitabine hydrochloride thereof
US7485716B2 (en) * 2005-05-02 2009-02-03 Pharmaessentia Corp. Stereoselective synthesis of β-nucleosides
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’，2’-二氟-胞苷合成的方法
EP1940859A1 (de) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited Verbessertes verfahren zur zubereitung von gemcitabinhydrochlorid
KR101259637B1 (ko) * 2005-12-14 2013-04-30 주식회사종근당 1-(2´-데옥시-2´,2´-디플루오로-디-리보푸라노실)-4-아미노피리미딘-2-온또는 그의 염산염의 제조방법
RU2345087C2 (ru) * 2006-02-06 2009-01-27 Др. Редди`С Лабораторис Лтд. Способ получения и очистки гемцитабина гидрохлорида
WO2008045419A1 (en) * 2006-10-10 2008-04-17 Pharmasset, Inc. Preparation of nucleosides ribofuranosyl pyrimidines
US20090069354A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched gemcitabine
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain Compounds, Compositions and Methods
EP2217247A4 (de) * 2007-11-06 2011-12-28 Pharmaessentia Corp Neue synthese von beta-nucleosiden
IT1393062B1 (it) * 2008-10-23 2012-04-11 Prime Europ Therapeuticals Procedimento per la preparazione di gemcitabina cloridrato
CA2757745C (en) * 2009-04-06 2018-02-13 Eisai Inc. Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
ES2593088T3 (es) * 2009-04-06 2016-12-05 Otsuka Pharmaceutical Co., Ltd. Derivados de (2'-Desoxi-Ribofuranosil)-1,3,4,7-Tetrahidro-(1,3)Diazepin-2-ona para Tratamiento de Cáncer
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
US8329666B2 (en) * 2009-04-06 2012-12-11 Eisai Inc. Compositions and methods for treating cancer
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
RU2538593C2 (ru) * 2009-05-15 2015-01-10 Дельта-Флай Фарма, Инк. НОВЫЕ СТАБИЛЬНЫЕ КРИСТАЛЛЫ МОНОГИДРОХЛОРИДА 1-(2-β-D-АРАБИНОФУРАНОЗИЛ)ЦИТОЗИНА
CN101628927B (zh) * 2009-08-07 2012-10-10 卡硼瑞（北京）科技有限公司 以1,3,5-三-O-苯甲酰基-α-D-呋喃核糖为原料立体选择性制备β-二氟胞苷盐酸盐的方法
CN102453064B (zh) * 2011-06-30 2014-07-09 江苏豪森药业股份有限公司 制备吉西他滨盐酸盐的方法
CN102659884B (zh) * 2012-04-23 2014-07-02 南京臣功制药股份有限公司 盐酸吉西他滨的提纯方法
CN103224541B (zh) * 2013-04-27 2015-07-01 江苏豪森药业股份有限公司 吉西他滨α-异构体转化回收工艺
CN104402945A (zh) * 2014-11-27 2015-03-11 苏州乔纳森新材料科技有限公司 一种3-脱氧-1,2-o-异丙叉-d-呋喃木糖的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817978A (en) * 1971-06-16 1974-06-18 Syntex Inc 4-fluoro nucleosides and sugar intermediates, and methods of preparing
JPS5924999B2 (ja) * 1978-06-10 1984-06-13 富山化学工業株式会社 新規な５−フルオロ−２′−デオキシ−β−ウリジン誘導体の製造法
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
AU4134793A (en) * 1992-06-22 1993-12-23 Eli Lilly And Company 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
IL106078A0 (en) * 1992-06-22 1993-10-20 Lilly Co Eli Stereoselective anion glycosylation process
CA2105112C (en) * 1992-09-01 2005-08-02 Thomas C. Britton A process for anomerizing nucleosides
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Also Published As

Publication number Publication date
KR100424991B1 (ko) 2004-05-20
GR3030265T3 (en) 1999-08-31
US5637688A (en) 1997-06-10
CO4520286A1 (es) 1997-10-15
ZA959320B (en) 1997-05-05
SI0719788T1 (en) 1999-10-31
HUT77929A (hu) 1998-11-30
UA48152C2 (uk) 2002-08-15
JPH10510806A (ja) 1998-10-20
MX9704322A (es) 1997-09-30
BR9509979A (pt) 1998-06-09
BG62738B1 (bg) 2000-06-30
NO306783B1 (no) 1999-12-20
CN1169728A (zh) 1998-01-07
DK0719788T3 (da) 1999-11-01
ES2130542T3 (es) 1999-07-01
WO1996018637A1 (en) 1996-06-20
TW379226B (en) 2000-01-11
RO117327B1 (ro) 2002-01-30
PE49296A1 (es) 1996-11-21
NZ296476A (en) 1998-12-23
AU689674B2 (en) 1998-04-02
PL321046A1 (en) 1997-11-24
EP0719788A2 (de) 1996-07-03
US5808048A (en) 1998-09-15
NO972679L (no) 1997-06-11
MY112488A (en) 2001-06-30
YU70895A (sh) 1998-09-18
DE69509624T2 (de) 1999-10-07
BG101591A (en) 1998-03-31
DE69509624D1 (de) 1999-06-17
EP0719788B1 (de) 1999-05-12
AR001041A1 (es) 1997-09-24
YU49314B (sh) 2005-06-10
EP0719788A3 (de) 1996-09-25
RU2154648C2 (ru) 2000-08-20
IL115852A0 (en) 1996-01-31
PL181732B1 (en) 2001-09-28
HU219021B (hu) 2001-01-29
CZ179897A3 (en) 1997-09-17
CZ290941B6 (cs) 2002-11-13
CN1047177C (zh) 1999-12-08
IL115852A (en) 1999-09-22
NO972679D0 (no) 1997-06-11
AU4110196A (en) 1996-07-03

Similar Documents

Publication Publication Date Title
ATE179986T1 (de) Verfahren zur herstellung von 1-(2'-deoxy-2',2'- difluoro-d-ribofuranosyl)-4-amino-pyrimidin-2-o - hydrochlorid
DE69620461D1 (de) Verfahren zur herstellung von 1,1,1,3,3,-pentafluoropropanen
DE69512250D1 (de) Verfahren zur herstellung von 1,1,1,3,3,3- hexafluorpropan
DE69617921D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluoropropan
DE69801489D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69713894D1 (de) Verfahren zur herstellung von 2,3-dihalogenpropanolen
DE69618476D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69915878D1 (de) Verfahren zur herstellung von 2,3-dihalogenpropanolen
DE69519379D1 (de) Verfahren zur herstellung von trifluorethylene
DE69726441D1 (de) Verfahren zur herstellung von 1,3-dioxolan-4-methanol-verbindungen
DE69603502D1 (de) Verfahren zur herstellung von 1,3-propandiol
DE69510466D1 (de) Verfahren zur herstellung von n-phosphonomethylglyzin
DE69510087D1 (de) Verfahren zur herstellung von 5-chlor-2,3-dihydro-1h-inden-1-on
DE69425496D1 (de) Verfahren zur herstellung von 1,4-dienen
DE69717115D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69724442D1 (de) Verfahren zur herstellung von 1,3-dioxolan-4-methanol-verbindungen
DE59905197D1 (de) Verfahren zur herstellung von hexandiol-1,6
ATE182143T1 (de) Verfahren zur herstellung von 1,2- benzisothiazolonen
DE59508742D1 (de) Verfahren zur herstellung 1,3-disubstituierter imidazolidinone
DE69612610D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluoropropan
ATE187959T1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE59510636D1 (de) Verfahren zur herstellung von 8-alpha,12-oxido-13,14,15,16-tetranorlabdan
DE69711039D1 (de) Verfahren zur herstellung von 1,3-alkandiolen
DE59509620D1 (de) Verfahren zur herstellung von acyloinen
DE69908374D1 (de) Verfahren zur herstellung von 3,5-difluoroanilin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification